Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of$ 0.78. This compares to loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 92.31%. A quarter ago, it was expected that this drug discovery and development company would post a loss of$ 1.01 per share when it actually produced a loss of $1.03, delivering a surprise of -1.98%.Over the last fo ...